Beta Bionics Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Beta Bionics Inc 公司

Beta Bionics, Inc. 是一家商業階段的醫療器械公司，致力於設計、開發和商業化各種解決方案，以改善需要胰島素的糖尿病患者 (PWD) 的健康。該公司的產品 iLet Bionic Pancreas (iLet) 是一種胰島素輸送裝置，經美國食品藥品管理局 (FDA) 批准，利用自適應閉環算法自主確定每次胰島素劑量，而無需用戶計算碳水化合物攝入量。iLet 用於治療 1 型糖尿病 (T1D)。該公司的解決方案包括成人版 iLet、兒童版 iLet、Bionic Circle App 和 iLet Simulator。該公司正處於開發胰島素泵的早期階段，該泵旨在直接粘附在皮膚上並無需導管即可給藥，在糖尿病行業中通常稱爲貼片泵。它還處於開發 iLet 雙激素配置的早期階段。

Beta Bionics Inc簡介



公司代碼BBNX

公司名稱Beta Bionics Inc

上市日期Jan 30, 2025

CEOMr. Sean Saint

員工數量291

證券類型Ordinary Share

年結日Jan 30

公司地址11 Hughes

城市IRVINE

上市交易所NASDAQ Global Market Consolidated

國家United States of America

郵編92618

電話19494277785

網址https://www.betabionics.com

公司代碼BBNX

上市日期Jan 30, 2025

CEOMr. Sean Saint

Beta Bionics Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Dr. Steven Russell, M.D., Ph.D.

Chief Medical Officer

71.02K

-1.41%

Ms. Christy Jones

Independent Director

59.44K

--

Mr. Gerard J. Michel

Independent Director

12.55K

--

Mr. Sean D. Carney

Independent Director

11.25K

--

Mr. Adam Lezack

Independent Chairman of the Board

9.84K

-12.50%

Dr. Maria Palasis, Ph.D.

Independent Director

9.84K

-12.50%

Mr. Blake Beber

Investor Relations

--

Mr. Sean Saint

President, Chief Executive Officer, Director

--

-100.00%

Mr. Dan Dearen

Independent Director

--

Mr. Stephen Feider

Chief Financial Officer

--

-100.00%

名稱

名稱/職務

職務

持股

持股變動

Dr. Steven Russell, M.D., Ph.D.

Chief Medical Officer

71.02K

-1.41%

Ms. Christy Jones

Independent Director

59.44K

--

Mr. Gerard J. Michel

Independent Director

12.55K

--

Mr. Sean D. Carney

Independent Director

11.25K

--

Mr. Adam Lezack

Independent Chairman of the Board

9.84K

-12.50%

Dr. Maria Palasis, Ph.D.

Independent Director

9.84K

-12.50%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2023

業務USD

名稱

營收

佔比

DME channel - iLet

13.41M

57.72%

DME channel - Single-use products

5.23M

22.51%

PBP channel - Single-use products

4.39M

18.89%

PBP channel - iLet

205.00K

0.88%

暫無數據

業務

地區

業務USD

名稱

營收

佔比

DME channel - iLet

13.41M

57.72%

DME channel - Single-use products

5.23M

22.51%

PBP channel - Single-use products

4.39M

18.89%

PBP channel - iLet

205.00K

0.88%

股東統計

更新時間: 9月3日週三

持股股東

股東類型

持股股東

佔比

Eventide Asset Management, LLC

11.20%

Farallon Capital Management, L.L.C.

9.55%

Wellington Management Company, LLP

8.86%

Soleus Capital Management, L.P.

8.68%

Sands Capital Ventures LLC

8.11%

其他

53.60%

持股股東

佔比

Eventide Asset Management, LLC

11.20%

Farallon Capital Management, L.L.C.

9.55%

Wellington Management Company, LLP

8.86%

Soleus Capital Management, L.P.

8.68%

Sands Capital Ventures LLC

8.11%

其他

53.60%

股東類型

持股股東

佔比

Hedge Fund

37.25%

Investment Advisor/Hedge Fund

32.15%

Investment Advisor

23.04%

Research Firm

7.30%

Venture Capital

5.69%

Private Equity

3.62%

Individual Investor

0.63%

Sovereign Wealth Fund

0.34%

Pension Fund

0.23%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

179

48.08M

109.20%

+5.53M

2025Q2

161

44.89M

103.27%

+24.04M

2025Q1

149

45.45M

104.86%

+26.05M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Eventide Asset Management, LLC

4.93M

11.35%

+4.33K

+0.09%

Jun 30, 2025

Farallon Capital Management, L.L.C.

4.20M

9.67%

+871.70K

+26.16%

Jun 30, 2025

Wellington Management Company, LLP

3.90M

8.98%

--

Jun 30, 2025

Soleus Capital Management, L.P.

3.82M

8.79%

+424.82K

+12.51%

Jun 30, 2025

Sands Capital Ventures LLC

3.57M

8.21%

+415.70K

+13.18%

Jun 30, 2025

RTW Investments L.P.

3.30M

7.59%

-679.00

-0.02%

Jun 30, 2025

Morgan Stanley & Co. LLC

2.92M

6.72%

+1.53M

+109.41%

Jun 30, 2025

The Vanguard Group, Inc.

706.97K

1.63%

-2.29K

-0.32%

Jun 30, 2025

Omega Fund Management, LLC

1.99M

4.57%

--

Jun 30, 2025

Perceptive Advisors LLC

1.59M

3.67%

--

Jun 30, 2025

持股ETF



更新時間: 11月6日週四

機構名稱

佔比

SPDR S&P Health Care Equipment ETF

0.89%

Invesco Dorsey Wright Healthcare Momentum ETF

0.61%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.42%

Global X Internet of Things ETF

0.34%

iShares U.S. Medical Devices ETF

0.09%

Goldman Sachs Innovate Equity ETF

0.06%

iShares Russell 2000 Growth ETF

0.04%

Proshares Ultra Russell 2000

0.03%

ProShares Hedge Replication ETF

0.03%

Global X Russell 2000 ETF

0.03%

SPDR S&P Health Care Equipment ETF

佔比0.89%

Invesco Dorsey Wright Healthcare Momentum ETF

佔比0.61%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比0.42%

Global X Internet of Things ETF

佔比0.34%

iShares U.S. Medical Devices ETF

佔比0.09%

Goldman Sachs Innovate Equity ETF

佔比0.06%

iShares Russell 2000 Growth ETF

佔比0.04%

Proshares Ultra Russell 2000

佔比0.03%

ProShares Hedge Replication ETF

佔比0.03%

Global X Russell 2000 ETF

佔比0.03%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據